Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma

Journal of Neuro-Oncology

Volumn 129, Issue 1, 2016, Pages 101-107

  Iwadate, Yasuo ^a   Matsutani, Tomoo ^a   Hirono, Seiichiro ^a   Shinozaki, Natsuki ^a   Saeki, Naokatsu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

EMT; Epithelial mesenchymal transition; Glioma; Hypoxia; Microenvironment; TGF

Indexed keywords

ALKALINE PHOSPHATASE; CD133 ANTIGEN; HERMES ANTIGEN; TEMOZOLOMIDE; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; CD44 PROTEIN, HUMAN; HYALURONIC ACID BINDING PROTEIN; NUCLEAR PROTEIN; PROM1 PROTEIN, HUMAN; TUMOR MARKER; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; SURVIVAL RATE; AGED; BRAIN TUMOR; CANCER STEM CELL; DISEASE FREE SURVIVAL; METABOLISM; MIDDLE AGED; NECROSIS; PATHOLOGY;

AC133 ANTIGEN; AGED; ALKALINE PHOSPHATASE; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GLIOBLASTOMA; HUMANS; HYALURONAN RECEPTORS; MALE; MIDDLE AGED; NECROSIS; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA; TWIST-RELATED PROTEIN 1;

EID: 84969816481     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-016-2145-6     Document Type: Article

References (41)

1. Aldape K, Zadeh G, von Deimling A et al (2015) Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol 129:829–848
2. Liu C, Sage JC, Miller MR et al (2011) Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146:209–221
3. Iwadate Y, Sakaida T, Hiwasa T et al (2004) Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res 64:2496–2501
4. Phillips HS, Kharbanda S, Chen R et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157–173
5. Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110
6. Zarkoob H, Taube JH, Singh SK, Mani SA, Kohandel M (2013) Investigating the link between molecular subtype of glioblastoma, epithelial- mesenchymal transition, and CD133 cell surface protein. PLoS One 8:e64169
7. Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8:3274–3284
8. Cooper LAD, Gutman DA, Chisolm C et al (2012) The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am J Path. 180:2108–2118
9. Charles NA, Holland EC, Gilbertson R et al (2011) The brain tumor microenvironment. Glia. 59:1169–1180
10. Jensen RL (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92:317–335
11. Mani SA, Guo W, Liao M-J et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715
12. Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760
13. Bhat KPL, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K et al (2013) Mesenchymal differentiation mediated by NF-kB promotes radiation resistance in glioblastoma. Cancer Cell 24:331–346
14. Zhang X, Zhang W, Mao XG, Zhen HN, Cao WD, Hu SJ (2013) Targeting role of glioma stem cells for glioblastoma multiforme. Curr Med Chem 20:1974–1984
15. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T et al (2008) Stem cell-related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 26:3015–3024
16. Ye X-Z, Xu S-L, Xin Y-H et al (2012) Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J Immunol 189:444–453
17. Piao Y, Liang J, Holmes L et al (2012) Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro-Oncology 14:1379–1392
18. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428
19. Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429–1437
20. Mikheeva SA, Mikheev AM, Petit A et al (2010) Twist1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer. 9:194
21. Shinojima N, Hossain A, Takezaki T et al (2012) TGF-β mediated homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells. Cancer Res 73:2333–2344
22. Kahlert UD, Nikkhah G, Maciaczyk J (2013) Epithelial-to-mesenchymal (-like) transition as a relevant molecular event in malignant gliomas. Cancer Let. 33:131–138
23. Rong Y, Durden DL, Van Meir EG et al (2006) ‘Pseudopalisading’ necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropath Exp Neurol 65:529–539
24. Bruna A, Darken RS, Rojo F et al (2007) High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cnacer Cell 11:147–160
25. Theys J, Jutten B, Habets R et al (2011) E-cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radioth Oncol 99:392–397
26. Meng J, Li P, Zhang Q et al (2014) A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway. Oncotarget 5:4683–4693
27. Hardee ME, Marciscano AE, Medina-Ramirez CM et al (2012) Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β. Cancer Res 72:4119–4129
28. Kim Y-H, Yoo K-C, Cui Y-H et al (2014) Radiation promotes malignant progression of glioma cells through HIF-1alpha stabilization. Cancer Lett 354:132–141
29. Zhou YC, Liu JY, Li J et al (2011) Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial- mesenchymal transition. Int J Radiat Oncol Biol Phys 81:1530–1537
30. Zhang M, Kleber S, Rohrich M et al (2011) Blockade of TGF-beta signaling by the TGFbetaR-1 kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Cancer Res 71:7155–7167
31. Timke C, Zieher H, Roth A et al (2008) Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improve radiation tumor therapy. Clin Cancer Res 14:2210–2219
32. Mahabir R, Tanino M, Elmansuri A et al (2014) Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. Neuro-Oncology 16:671–685
33. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62
34. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177:1491–1502
35. Evans SM, Judy KD, Dunphy I et al (2004) Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10:8177–8184
36. Li Z, Bao S, Wu Q et al (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15:501–513
37. Kaur B, Khwaja FW, Severson EA et al (2005) Hypoxia and hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7:134–153
38. Shahrzad S, Bertrand K, Minhas K, Coomber BL (2007) Induction of DNA hypomethylation by tumor hypoxia. Epigenetics 2:119–129
39. Skowronki K, Andrews J, Rodenhiser DI, Coomber BL (2014) Genome-wide analysis in human colorectal cancer cells reveals ischemia-mediated expression of motility genes via DNA hypomethylation. PlosOne 9: e103243
40. Schonberg DL, Lubelski D, Miller TE, Rich JN (2014) Brain tumor stem cells: molecular characteristics and their impact on therapy. Mol Aspects Med 39:82–101
41. Bechnan J, Isakson P, Joel M et al (2014) Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression. Stem Cells 32:1110–1123